Session I: Lessons Learned from Patient Medication Information Projects
To view the webcast archive click here.
In order to take their medications safely and effectively, patients need medication information that is accurate, balanced, and delivered in an easily understood format. However, the current sources of written prescription information patients receive are numerous, uncoordinated, and sometimes conflicting.
To address the pressing need for high-quality medication information, the U.S. Food and Drug Administration (FDA), the Engelberg Center for Health Care Reform, and other stakeholders from throughout the biomedical ecosystem have worked over the past several years to establish a new single-document format called Patient Medication Information (PMI). As part of an ongoing cooperative agreement between the Engelberg Center and FDA, this event highlighted progress-to-date on the PMI initiative. Stakeholder helped identify opportunities to improve the clarity and content of consumer medication information; disseminate key takeaways and best practices; and determine next steps for realizing the full potential of PMI.